Serum leptin levels are associated with tamoxifen-induced hepatic steatosis

Gunel N., Coskun U., Toruner F., Sancak B., Yilmaz E., Cengiz O., ...Daha Fazla

CURRENT MEDICAL RESEARCH AND OPINION, cilt.19, sa.1, ss.47-50, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 1
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1185/030079902125001308
  • Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.47-50
  • Anahtar Kelimeler: breast cancer, hepatic steatosis, leptins, tamoxifen, BREAST-CANCER PATIENTS, NONALCOHOLIC STEATOHEPATITIS, POSTMENOPAUSAL PATIENTS, WOMEN, HYPERTRIGLYCERIDEMIA, THERAPY, WEIGHT
  • Ankara Üniversitesi Adresli: Evet

Özet

Purpose: Tamoxifen, used in breast cancer treatment, may induce hepatic steatosis. It has been suggested that leptin, which, has a relationship with body fat stores, may be involved in the pathogenesis of hepatic steatosis. In this study, we compared serum leptin levels in tamoxifen-treated patients with and without hepatic steatosis.